🇺🇸 FDA
Patent

US 6485746

Controlled-release sedative-hypnotic compositions and methods related thereto

expired A61KA61K9/2081A61K9/209

Quick answer

US patent 6485746 (Controlled-release sedative-hypnotic compositions and methods related thereto) held by Neurocrine Biosciences, Inc. expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K9/2081, A61K9/209, A61K9/5084